
Sign up to save your podcasts
Or


The Brilliance phototherapy device has touched the lives of over 1 million neonates with jaundice. Their trick? Probing deep into health systems to ask:
In Part 2 of this series spotlighting neonatal health technologies designed for low-resource settings, I welcome Krishnakumar Sankaranarayanan (KK), former MD of Equalize Health India. Join us as we uncover the technology and market strategy behind the successful adoption of Brilliance phototherapy device.
Along the way, we explore the cost-quality tradeoff in engineering and why pharma giants haven’t been able to bridge the accessible tech gap just yet.
References:
Human-Centered Design Case Series Featuring “Brilliance”
Equalize Health Impact Audit
Music License Codes: 6RZ1QCMLRU5EUREW, UJMANWNDBCJ8SCFV, FBBXCULZLH4SQGLZ
By Smiti MittalThe Brilliance phototherapy device has touched the lives of over 1 million neonates with jaundice. Their trick? Probing deep into health systems to ask:
In Part 2 of this series spotlighting neonatal health technologies designed for low-resource settings, I welcome Krishnakumar Sankaranarayanan (KK), former MD of Equalize Health India. Join us as we uncover the technology and market strategy behind the successful adoption of Brilliance phototherapy device.
Along the way, we explore the cost-quality tradeoff in engineering and why pharma giants haven’t been able to bridge the accessible tech gap just yet.
References:
Human-Centered Design Case Series Featuring “Brilliance”
Equalize Health Impact Audit
Music License Codes: 6RZ1QCMLRU5EUREW, UJMANWNDBCJ8SCFV, FBBXCULZLH4SQGLZ